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Effect of acute treatment with progesterone on the timing and
synchrony of ovulation in Bos indicus heifers treated with a
norgestomet implant for 17 days
J. Cavalieri, J. E. Kinder and L. A. Fitzpatrick
1Australian Institute of Tropical Veterinary & Animal Science, and zDepartment of Physiology and
Pharmacology, fames Cook University of North Queensland, Townsville, Q 4811, Australia; and
3Department of Animal Science, University of Nebraska, Lincoln, NE 68583-0908, USA
The aim of the present study was to develop a treatment protocol for the precise
synchronization of oestrus that would avoid the development of persistent dominant
ovarian follicles. Bos indicus heifers, in which oestrous cycles had been presynchronized, were
allocated randomly, according to the day of their oestrous cycle, to one of five treatment
groups. All heifers received a subcutaneous ear implant containing 3 mg of norgestomet for
17 days starting on day 0 and an injection of an analogue of prostaglandin F2\g=a\on days 0
and 4. Heifers in group 1 (control group; n = 7) received no other treatment, while heifers
in groups 2 (n = 8), 3 (n = 7), 4(n = 7), and 5 (n= 7) received a single progesterone-releasing
controlled internal drug release device (CIDR) for 24 h on days 10, 12, 14 and 16,
respectively. Treatment with a single CIDR delayed the mean time of ovulation and the day
of emergence of the ovulatory follicle in heifers treated on days 14 and 16 compared with
control heifers (P<0.05). There was less variation in the interval to ovulation in heifers
treated on day 10 compared with other treated heifers (P < 0.05). The variation among
heifers in the day of emergence of the ovulatory follicle and the age of
the ovulatory follicle at ovulation was less for all groups treated with a CIDR than for the
control group (P<0.05). The duration of dominance and variation in the duration of
dominance of the ovulatory follicle was less in heifers treated with a CIDR device on days
10 and 16 than for control heifers (P < 0.05). Mean age (days from emergence to ovulation)
of the ovulatory follicle did not differ among treatment groups (P > 0.05). Concentrations of
LH and oestradiol decreased coincident with increased concentrations of progesterone on
the days of CIDR treatment in treated compared with control heifers (P < 0.02) but
increased again after removal of the CIDR. A smaller proportion of follicles in the growing
phase of follicular development at the time of CIDR treatment become atretic compared
with follicles that had reached a plateau phase of follicular growth (14.3% (1/7) versus 90.5%
(19/21), respectively; P < 0.001). It was concluded that acute treatment with progesterone
can influence the growth pattern of ovarian follicular development. However, the effect
varies with the stage of ovarian follicular development. Short term treatment with
progesterone 7 days before the end of a 17 day period of norgestomet treatment resulted
in precise synchrony of ovulation without the ovulation of a persistent dominant ovarian
follicle.
Introduction
Progestogens are commonly used to synchronize oestrus in
cattle by synchronizing the end of the progestational phase of
the oestrous cycle (Odde, 1990; Wright and Malmo, 1992).
However, while progestin-based systems of synchronizing
oestrus are widely used and provide good control of the
oestrous cycles of cattle, fertility at the synchronized oestrus
has been variable (Miksch et al, 1978; Spitzer et al, 1978;
Rentfrow et al, 1987; Brown et al, 1988; Favero et al, 1988;
Odde, 1990). The reduction in fertility associated with the
use of progestogens, in concentrations normally used to
synchronize oestrus, has been attributed to abnormal oocyte
development (Kinder et al, 1996).
When progestogens are administered in the absence of a
functional corpus luteum at doses that are used commercially to
synchronize oestrus, there is an increase in the frequency of
release of LH from the anterior pituitary gland, the increase in
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peripheral concentrations of oestradiol is prolonged and ovar¬
ian follicles that are persistent develop, all of which are
associated with a reduction in fertility at the synchronized
oestrus (Savio et al, 1993; Cooperative Regional Research
Project, 1996; Kinder et al, 1996). Treatments designed to
prevent either the development of persistent follicles (Sanchez
et al, 1993; Wehrman et al, 1993; Cooperative Regional
Research Project, 1996) or induce recruitment of a new
dominant follicle (Schmitt et al, 1996) have resulted in an
improvement in fertility at the synchronized oestrus. Fertility is
not compromised when the duration of dominance of the
ovulatory follicle is limited to 4 days or fewer (Mihm et al,
1994). Effective methods to synchronize oestrus should, there¬
fore, synchronize either ovarian follicular development, the
time of individual luteal regression, or the end of a period of
progestogen treatment. In addition, treatment should prevent
prolonged and increased peripheral concentrations of oestra¬
diol or an increase in the frequency of LH secretion and avoid
prolonged periods of dominance of the ovulatory follicle.
Acute treatment with progesterone during a period of
progestogen treatment results in atresia of persistent ovarian
follicles and improves fertility at the synchronized oestrus in
Bos taurus cattle (Anderson and Day, 1994). However, the
effects of acute treatment with progesterone in Bos indicus
heifers and the timing of such treatment relative to the end of
the period of progestogen treatment on the synchrony of
ovulation and its influence on ovarian follicular development
have not been determined. The objective of the present study
was to synchronize the time of ovulation in heifers without the
development of a persistent dominant ovarian follicle and to
determine the optimum time for short-term treatment with
progesterone relative to the end of the period of progestogen
treatment, that would result in the best synchrony of ovulation.
Our aim was to develop a protocol for synchronizing behav¬
ioural oestrus that would result in precise synchrony of
ovulation with normal fertility.
Materials and Methods
Animals and treatments
The study was conducted in spring. Serial ultrasound exami¬
nation was used to confirm cyclic ovarian activity in 36,
2-year-old Bos indicus heifers (7/8 to 15/16 Brahman; mean
weight ± sem: 347.4 ± 7.2 kg). The stage of the oestrous cycle
was then synchronized with a s.c. silicone implant containing
3 mg of norgestomet (17a-acetoxy-llß-methyl-19-norpreg-4-
en-3,20 dione; Crestar B, Intervet (Aust), Castle Hill, NSW), for
9 days and an i.m. injection of an analogue of prostaglandin F2o
(PGF2a; 15 mg Prosolvin1®, Intervet (Aust), Castle Hill, NSW)
on the day of implant insertion and removal. Ten days after the
implants had been removed (day 0), heifers were allocated
randomly, according to the day of their oestrous cycle (days 2
to 5,  = 7; day 6,  = 9; day 7, n = 12; and day 8,  = 8;
respectively), to one of five treatment groups. All heifers
received a single s.c. norgestomet ear implant (3 mg) on day 0
that was removed 17 days later and were injected with 15 mg
PGF2(1 analogue on days 0 and 4 to induce regression of
corpora lutea. A preliminary study had confirmed that a 3 mg
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Fig. 1. Diagrammatic representation of treatment protocol. The open
rectangles represent a single subcutaneous norgestomet implant
inserted into heifers from days 0 to 17. A progesterone-releasing
controlled internal drug releasing device (shaded rectangles) was
inserted on day 10 (PIO), day 12 (P12), day 14 (P14) or day 16 (P16)
and removed the following day. An injection of an analogue of
prostaglandin F2lI (PG) was given to all heifers on days 0 and 4.
Implants were removed from all animals on day 17.
norgestomet ear implant would maintain Bos indicus heifers in
anoestrus for at least 21 days (J. Cavalieri, unpublished). Heifers
in the control group (control,  = 7), received no other treat¬
ment. A progesterone-releasing controlled internal drug release
(CIDR) device was inserted into the vagina of the remaining
heifers for 24.2 ± 0.06 h (mean ± sem) either on day 10 (PIO,
 = 8), day 12 (P12,  = 7), day 14 (P14,  = 7) or day 16 (Pió,
 = 7; Fig. 1).
Ultrasonography
The ovaries of heifers were examined using transrectal
ultrasonography (Aloka 210 DX: 7.5 Mhz probe), by the same
operator, on alternate days from days 0 to 10, then once a day
until signs of behavioural oestrus were detected. The ovaries of
heifers were then examined every 6 h until ovulation was
detected. The stage of growth of ovarian follicles at the time of
treatment with progesterone was categorized as either in the
growing phase (when a follicle was 5—9 mm in diameter and
still increasing in size) or as in the plateau phase (when there
had been no increase in the size of the dominant follicle for 2
consecutive days or the dominant follicle was > 10 mm in
diameter. The mean maximum diameter of dominant follicles in
Bos indicus heifers has been reported as 10 mm (Rhodes et al,
1994). A new wave of follicular development always began
before regression of the dominant follicle had been detected.
The day of emergence of the ovulatory follicle was defined,
retrospectively, as the day on which the ovulatory follicle was
first detected at a size of > 5 mm in diameter. The age of the
ovulatory follicle was defined as the time interval (days)
between the day of emergence of the ovulatory follicle and the
time of ovulation. The first day of dominance of the ovulatory
follicle was defined using the criteria described by Mihm et al
(1994), that is, the first day that (1) subordinate follicles stop
increasing in diameter, (2) the ovulatory follicle was >8.5 mm,
or (3) the diameter of the ovulatory follicle was > 2 mm larger
than any subordinate follicles (not essential). The duration of
dominance of the ovulatory follicle (days) was defined as the
interval between the first day of dominance and the day of
ovulation minus one day.
Blood sampling and radioimmunoassays
Concentrations of progesterone in plasma were measured in
unextracted plasma samples by radioimmunoassay using a
modification of the Danazol method (McGinley and Casey,
1979) described by Jolly (1992). The sensitivity of the assay
(90% zero-binding) was 0.03 ng ml_ 1 and intra- and inter¬
assay coefficients of variation at the approximate mid-point of
the standard curve (1.0 ng ml" ) were 13.1% and 16.1%,
respectively.
Concentrations of plasma LH were measured by double-
antibody radioimmunoassay, using a modification of the
method described by Niswender et al (1969) that has been
validated in our laboratory (Rhodes et al, 1995a). Purified
bovine LH (USDA-bLH-B-6, AFP-11743-B) was provided
by D. Bolt (USDA Animal Hormone Program, Beltsville,
MD, USA). The antiserum used was NIDDK-anti-oLH-1
(AFP-192279), which was supplied by NIDDK, Bethesda, MD.
The sensitivity of this assay (90% of zero-binding) was
0.2 ng ml ~
.
Intra- and interassay coefficients of variation were
13.5% and 16.5%, respectively.
Concentrations of plasma oestradiol were determined
by radioimmunoassay in the Physiology Laboratory of the
University of Nebraska, using antiserum to oestradiol (lot no.
022367) provided by N. R. Mason (Lilly Research Laboratories,
Indianapolis, IN) and oestradiol, (Sigma Chemical Co., St. Louis,
MO) as standard. The procedure for this assay has been
reported and validated by Kojima et al (1992). The sensitivity
of this assay (90% of zero binding) was 0.07 pg ml ~ \ Intra-
and interassay coefficients of variation were 13.4% and 16.4%,
respectively.
Statistical analyses
Initial data analysis suggested highly variable non-normal
distribution of data. Therefore, bootstrap estimates of location
(mean) and spread (sd) were used for the variables, age of
follicle (number of days between emergence and ovulation of
follicle), day of emergence and duration of dominance of the
ovulatory follicle, and time elapsing from implant removal to
ovulation. The bootstrap is a recently developed technique
for making certain types of statistical inferences (Efron and
Tibshirani, 1993). Bias corrected and accelerated estimates were
used to calculate both estimates and confidence intervals (CIs;
Efron and Tibshirani, 1993) using the bootstrap library pro¬
vided in Statlab (Splus, StatSci Division, MathSoft Inc., Seattle,
Washington, 1995). Splus 3.3 for Windows was used to run the
library.
For the purposes of comparisons of means and SD among
treatment groups, the 90% CIs can be used as follows.
Non-overlapping 90% CIs represent a significant difference at
approximately the 1% level of significance. This makes no
allowance for multiple comparisons and is hence equivalent to
performing multiple I tests. Multiple comparisons using the
Bonferoni method were catered for by increasing the level of
1% by approximately the number of tests used. Thus, if
each group is to be compared with the control (that is,
four comparisons), then the level of significance would be
marginally less than 5%.
Endocrine concentrations were log transformed (base 10) to
achieve constant variance over the sampling period. Changes in
plasma concentrations of progesterone, LH, and oestradiol over
time were analysed for effects of group, day and group-by-day
interaction using multivariate repeated measures analysis of
variance (Lindsey, 1993). If the group effect or the day-by-
group effect was significant (P<0.05), means of individual
treatment groups were compared with the control group using
Student's I test. The proportion of either growing (5—9 mm in
diameter) or plateau phase ovarian follicles, present at the start
of treatment with progesterone, that became atretic and did not
ovulate was compared using a two-tailed Fisher's exact test
(Bradley, 1968).
Results
One animal in the P16 group failed to ovulate within 10 days
of implant removal and data from this animal were excluded
from analyses pertaining to follicular growth, but were
included in the analyses of endocrine changes.
Endocrine changes
For the purpose of statistical analysis, changes in concen¬
trations of hormones over time were divided into two time
periods, days 0-10 and days 10-18. Changes in concentrations
of oestradiol, LH and progesterone for each treatment group
from days 0 to 18 are shown (Fig. 2).
Days 0 to 10. There was a significant effect of day
(P< 0.001), but no group (P> 0.270), or group-by-day inter¬
action (P > 0.280) on plasma concentrations of progesterone,
oestradiol and LH between days 0—10. Mean ( ± sem) concen¬
trations of progesterone declined (P < 0.001) from day 0
(3.023 ± 0.267 ng ml " ') to day 2 (0.525 ± 0.065 ngmr1) and
remained at basal concentrations in all groups until day 10.
Concentrations of LH initially increased (P < 0.001) from day 0
to day 2, decreased (P< 0.001) from day 2 to day 6 and then
increased (P< 0.001) again by day 10. Concentrations of
oestradiol increased (P< 0.001) from day 0 to day 10.
Days 10 to 18. A significant group-by-day interaction
(P < 0.001) was detected for plasma concentrations of proges¬
terone between days 10 and 18. Insertion of a CIDR device for
24 h resulted in increased concentrations of progesterone in the
treated animals compared with the control animals during the
period of CIDR treatment (P < 0.001). Mean concentrations of
progesterone in the plasma of treated heifers at the time of
removal of the CIDR ranged between 4.196 and 4.879 ng
ml
~
, while mean concentrations of progesterone in plasma
of the control heifers were < 0.250 ng ml ~ on each of the
days CIDRs were in place. Concentrations of progesterone
decreased to mean basal values of < 0.7 ng mH
' in each of
the treated groups 24 h after removal of the CIDR. Luteal
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regression did not occur in one heifer in group PIO until day 14
and this contributed to the group effect (P = 0.033) detected
between days 10 and 18.
A group-by-day interaction (P< 0.001) was detected for
concentrations of LH between days 10 and 18. At the time of
removal of the CIDR, mean concentrations of plasma LH in
each group of treated heifers were lower than concentrations of
LH in control heifers (control versus PIO, P14, P16,  < 0.01;
control versus  12,  =0.02). Mean concentrations of LH in
heifers in groups 2, 3, 4 and 5 at the time of CIDR removal
were 53, 41, 61 and 45%, respectively for each group, lower
than concentrations of LH in the control heifers. Mean concen¬
trations of LH in animals in groups PIO, P12 and P14 increased
24 h after removal of the CIDR and were not different from
concentrations in the control heifers (P> 0.150). Although
concentrations of LH in heifers in group P16 increased from
day 17 to day 18, LH concentrations in these heifers on day 18
was still significantly lower (P = 0.040) than corresponding LH
concentrations in the control heifers, due to the recording of a
preovulatory LH surge in some of the control animals.
A group-by-day interaction (P < 0.001) was detected for
concentrations of oestradiol between days 10 and 18. Mean
circulating concentrations of oestradiol at the time of CIDR
removal had decreased by 85%, 84%, 82%, 91%, respectively,
for groups PIO, P12, P14 and P16, when compared with the
time of CIDR insertion. Concentrations of oestradiol were
lower in all treatment groups at the time of CIDR removal than
the respective concentrations of oestradiol in the control
heifers on that day (P < 0.001). Concentrations of oestradiol in
the plasma of treated heifers increased after removal of CIDR
devices. The times required for mean concentrations of oestra¬
diol to increase, after progesterone withdrawal, to within the
95% confidence interval of the mean concentration of oestra¬
diol for the 2 days before treatment, were 5, 3, 4 and 6 days for
groups PIO, P12, P14 and P16, respectively.
Ovarian follicular development
During the 17 day period of norgestomet treatment, heifers
from the control and PIO groups had two or three waves of
follicular development, while heifers in groups P12—P16 had
two, three or four waves of follicular development. Treatment
with a CIDR device for 24 h delayed ovulation and the day of
emergence of the ovulatory follicle only in animals treated
within 3 days of implant removal (groups P14 and P16)
(P < 0.05; Fig. 3). A greater variability in the time of ovulation
was evident in the P12 and P16 animals compared with the
control animals and in the P16 animals compared with PIO, P12
and  14 heifers. Variability in the time of ovulation between
the PIO, P14 groups and the control group was similar
(P > 0.05; Fig. 3). The day of emergence of the ovulatory
follicle varied less among heifers in each of the four treatment
groups compared with heifers in the control group (P < 0.05;
Fig. 3). There was a trend towards a reduction in the mean age
of the ovulatory follicle in the treated animals compared with
control animals, although the difference was never significant
(P > 0.0; Fig. 4). The age of the ovulatory follicle, however,
varied more among the control animals than among any of the
animals in the other four treatment groups (P < 0.05, Fig. 4).
The mean duration of dominance (days) of the ovulatory
follicle was less in animals treated on day 10 and day 16, but
also varied less in animals treated on days 10, 14 and 16
compared with the control animals (P < 0.05, Fig. 4). None of
the ovarian follicles observed in animals in the PIO group at the
beginning of treatment with progesterone could be retrospec¬
tively identified as the ovulatory follicle. However, in 57.1%
(4/7), 28.6% (2/7) and 33.3% (2/6) of animals in groups 3, 4 and
5, respectively, the ovulatory follicle could retrospectively be
identified as being present in the ovary at the time when
treatment with progesterone began. The growth of the ovula¬
tory follicle for each animal in each treatment group is shown
(Fig. 5). The probability of causing atresia of ovarian follicles in
animals treated with progesterone differed according to stage
of follicular growth at the time of treatment with progesterone.
A smaller proportion of follicles that were in the growing
phase (5-9 mm in diameter) of follicular development became
atretic as a result of treatment with progesterone when
compared with follicles that had reached the plateau phase
of follicular growth (14.3% (l/7) versus 90.5% (19/21),
respectively;  < 0.001).
Discussion
The results of the present study are in agreement with the
findings of others who have reported that acute treatment with
progesterone can induce atresia of dominant ovarian follicles
and the emergence of a new wave of follicular development
(Rajamahendran and Manikkam, 1994; Anderson and Day,
1994). Data from the present study, however, indicate that the
time when progesterone treatment is administered, relative to
the end of a period of norgestomet treatment, will affect the
timing and synchrony of ovulation. Treatment with progester¬
one, 7 days before (day 10) the removal of norgestomet
implants, provided the best balance between achieving a
precise time of ovulation and avoiding the ovulation of an aged
oocyte. Mihm et al (1994) demonstrated that a sequential
reduction in pregnancy rates occurred as the duration of
dominance of the largest follicle increased from 4 days to 8
days in heifers in which oestrus was synchronized with
norgestomet, while no pregnancies occurred in heifers in which
the duration of follicular dominance exceeded 10 days (Mihm
et al, 1994). In studies in which small doses of progestins were
used, the extension of periods of follicular dominance resulted
in a reduction in fertility (Savio et al, 1993; Stock and
Fortune, 1993; Cooperative Regional Research Project, 1996).
Acute treatment with progesterone 7 days before ending
Fig. 2. Profiles of mean ( ± sem) concentrations of (a) progesterone, (b) LH and (c) oestradiol in heifers treated with a norgestomet implant for 17
days (starting on day 0) and an injection of an analogue of prostaglandin F2a (PG) on days 0 and 4. Heifers in the control group (O) received
no other treatment. Heifers in groups PIO (·), P12 ( ), P14 ( ) and P16 (V) were treated with a progesterone-releasing controlled internal
drug releasing device for 24 h starting on days 10, 12, 14 and 16, respectively.
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Fig. 3. Bootstrap estimates of location (mean) and spread (sd) ( ± 90% confidence interval) of the time interval
from the end of norgestomet treatment to ovulation and day of emergence of the ovulatory follicle.
Non-overlapping 90% confidence intervals differ (P < 0.05). Heifers were treated with a norgestomet implant for
17 days (starting on day 0) and an injection of an analogue of prostaglandin F2u on days 0 and 4. Heifers in the
control group received no other treatment. Heifers in groups PIO, P12 , P14 and P16 were treated with a
progesterone-releasing controlled internal drug releasing device for 24 h starting on days 10, 12, 14 and 16,
respectively.
norgestomet treatment offers the advantage of producing
precise ovulation synchrony while at the same time preventing
ovulation of persistent dominant follicles and would, therefore,
be expected to result in normal fertility.
Variability of synchrony of ovulation occurred in Bos indicus
cows when they were treated with a CIDR device for 10 days
(day 0 to day 10) and then treated with an additional CIDR
device for 48 h from day 8 to day 10 (Cavalieri et al, 1997). It
was concluded in that study that variation among animals in
the timing of emergence of ovulatory follicles, follicular growth
rates and maturation times for ovarian follicles after the
administration of the atretogenic treatment could have contrib¬
uted to the variability of ovulation synchrony that was
observed. In addition, a longer period of progestin treatment
after the application of an atretogenic treatment might be
needed to improve the synchrony of ovulation. The results of
the study reported here confirm that acute treatment with
progesterone at the end of a period of progestogen treatment
does result in a variable pattern of ovulation synchrony and
that increasing the time interval between progesterone treat¬
ment and extending the period of progestogen treatment to
7 days improves ovulation synchrony.
Two to three waves of ovarian follicular development were
detected in the control animals even though regression of
corpora lutea was induced early during the period of nor¬
gestomet treatment. This finding contrasts with previous
studies in which the use of single s.c. norgestomet implants in
Bos taurus cattle, in the absence of a corpus luteum, increased
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LH pulse frequency and prolonged the maintenance of domi¬
nant ovarian follicles (Savio et al, 1993; Taylor et al, 1993,
1994). In cows undergoing normal oestrous cycles, the pres¬
ence of basal concentrations of gonadotrophins during the
luteal phase of the oestrous cycle results in regular waves of
ovarian follicular development (Fortune, 1993). It would appear
that concentrations of circulating norgestomet were sufficient,
in some of the heifers in the control group in the present study,
to allow the continued periodic emergence of follicular waves
during the implantation period. Differences in genotype,
sensitivity to circulating concentrations of norgestomet, body-
weight or the timing of insertion of the norgestomet implants
might explain why dominant follicles were not maintained for
the duration of progestogen treatment in the control heifers in
the present study. Greater fertility and differing patterns of
release of norgestomet have been observed when norgestomet
was administered in silicone as opposed to hydron implants
(Kesler et al, 1995), which might indicate that persistent
dominant follicles are less common when silicone implants are
used to administer norgestomet. Acute treatment with proges¬
terone offers an additional means of reducing variability in the
growth pattern of the ovulatory follicle in heifers implanted
with a norgestomet implant.
The reduction in observed variability in the growth pattern
of the ovulatory follicle in most heifers treated with progester¬
one was due to treatment rendering most follicles anovulatory.
Acute treatment with progesterone, however, was more effec¬
tive in follicles that had reached a plateau phase in growth at
the time of treatment compared with follicles still in the
growing phase. This finding indicates that the development
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Fig. 5. Pattern of emergence and growth of the ovulatory follicle for
each heifer in each treatment group, up until ovulation was detected,
as recorded by transrectal ultrasonography. (0) indicates the presence
of a progesterone-releasing controlled internal drug releasing device;
(O) indicates time ovulation was detected. Heifers were treated with
a norgestomet implant for 17 days (starting on day 0) and an injection
of an analogue of prostaglandin F2a on days 0 and 4. Heifers in the
control group received no other treatment. Heifers in groups PIO,
P12, P14 and P16 were treated with a progesterone-releasing con¬
trolled internal drug releasing device for 24 h starting on days 10, 12,
14 and 16, respectively.
and maintenance of dominant follicles are less likely to be
arrested by exogenous treatment with progesterone during the
growing stages of ovarian follicular growth. Differences in the
sensitivity of ovarian follicles to atresia resulting from treat¬
ment with progesterone may relate to the number of LH
receptors present in a follicle and to the dependence of a follicle
on LH for continued viability. Dominant, gonadotrophin-
dependent, ovarian follicles are thought to be able to survive in
an environment of reducing concentrations of FSH because of
their increased sensitivity to FSH. LH receptors in granulosa
cells, therefore, are transferring their gonadotrophic require¬
ment from FSH to LH (Scaramuzzi et al, 1993; Campbell et al,
1995). This change, however, makes dominant follicles
critically dependent on LH for survival, and so the reduction
in mean LH concentrations observed in the present study,
coincident with progesterone treatment, may have deprived
dominant follicles of sufficient aromatisable substrate and
thereby, initiated atresia. During the early stages of growth,
those follicles, that are less dependent on LH for their survival,
would be less susceptible to acute treatments with progester¬
one which reduce the frequency of pulsatile LH secretion
(Rajamahendran and Manikkam, 1994). Therefore, in cattle, in
which oestrus has been synchronized with progestogens, acute
treatment with progesterone is more likely to render anovula¬
tory those follicles that had achieved a functional state of
dominance at the time of treatment, as these follicles would be
more susceptible to a reduction in LH secretion. This would
explain why in the study described here, actively growing
follicles were less susceptible to the atretogenic effects of
treatment with progesterone.
Atresia of all dominant or growing follicles that were
observed in the ovaries at the time of treatment with proges¬
terone was achieved in the PIO heifers as a result of treatment.
This atresia resulted in a more synchronous emergence of the
ovulatory follicle in this group and may have contributed to
the more precise timing of ovulation observed compared with
heifers in the other progesterone-treated groups. One step
towards improving ovulation synchrony might be to improve
the efficiency of atretogenic treatments. The results of the
present study suggest that this could be achieved by inducing
the development of a persistent dominant follicle, before
administration of the atretogenic treatment, by treatment with
progesterone at concentrations that are lower than usually
occur during a normal luteal phase of an oestrous cycle ( < 3 ng
ml ), or by using concentrations of progestogens that are
used commercially to synchronize oestrus in the absence of a
corpus luteum (Sirois and Fortune, 1990; Adams et al, 1992;
Savio et al, 1993; Stock and Fortune, 1993; Cooperative
Regional Research Project, 1996).
The reduction in mean concentrations of LH in plasma 24 h
after the beginning of treatment with progesterone is in
agreement with previous findings in both Bos indicus cows
(Cavalieri et al, 1997), and Bos taurus heifers (Burke and
Macmillan, 1995; Bergfeld et al, 1996) treated with exogenous
progesterone. The decline in mean concentrations of oestradiol
during the period of progesterone treatment and subsequent
increase after the removal of CIDR devices is probably due to
changes in both the secretory pattern of LH and the disruption
of the functional integrity of dominant follicles by progester¬
one treatment. Production of oestradiol is related to the
frequency of LH pulses (Walters et al, 1984; Rhodes et al,
1995a). Thus, the reduction in mean concentrations of oestra¬
diol is consistent with the reduction in mean concentrations of
LH in the present study.
The increase in mean concentrations of LH in each group of
heifers treated with progesterone after treatment had stopped
was probably due to a reduction in progesterone-mediated
negative feedback on LH secretion after the removal of the
CIDR devices; progesterone is known to affect the pulsatile
secretion of LH in a dose-dependent manner (Ireland and
Roche, 1982; Roberson et al, 1989; Bergfeld et al, 1995,
1996). Mean concentrations of oestradiol, however, increased
at a variable rate after the removal of CIDR devices with
concentrations of oestradiol taking between 3 and 6 days to
increase to pretreatment values.
Other studies have shown that atresia of dominant follicles
is associated with a reduced capacity for secretion of oestradiol
(Sunderland et al, 1994; Rhodes et al, 1995b). Thus, our results
are consistent with progesterone treatment causing a loss of
functional dominance of ovarian follicles. The more rapid
increase in oestradiol concentrations in, for example, the heifers
in the P12 group was probably due to a smaller proportion of
follicles being rendered anovulatory by the treatment. LH
concentrations were reduced only for the first 24 h of CIDR
treatment, yet atresia of dominant follicles was still observed in
most heifers treated with progesterone. This result supports the
contention of Anderson and Day (1994) that only a transient
reduction in LH secretion is needed to induce atresia of
dominant follicles. Whether there is a critical threshold for
circulating concentrations of progesterone, or a critical duration
for the presence of physiological concentrations of progester¬
one that is necessary before a dominant follicle is rendered
anovulatory remains to be determined. In addition, whether the
dose and duration of progesterone that is necessary to cause
atresia varies with the stage of follicular development also
requires further investigation.
In conclusion, the findings reported here indicate that acute
treatment with progesterone during a period of norgestomet
treatment can reduce variation in the day of emergence, and
the age and duration of a dominant follicle, and, therefore,
could be used to improve fertility in animals in which the stage
of oestrous cycles has been synchronized with progestogens.
However, extensive field trials are needed to test the potential
of this treatment protocol. The timing and synchrony of
ovulation were influenced by the timing of acute treatment
with progesterone relative to the end of progestogen treat¬
ment. Treatment with progesterone, 7 days before the ending
of a 17 day period of norgestomet treatment, resulted in
precise synchrony of ovulation and prevented the ovulation of
a persistent dominant ovarian follicle. Susceptibility of ovarian
follicles to atresia during exogenous treatment with progester¬
one also varies with stage of follicular development and this
will need to be considered when designing treatments to
synchronize oestrus.
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